Work

A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers

Year: 2011

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdq736

Authors: J.K. Salama, D.J. Haraf, K.M. Stenson, E.A. Blair, M.E. Witt, R. Williams, R. Kunnavakkam, E.E.W. Cohen, T. Seiwert, E.E. Vokes

Institutions: Duke University, University of Chicago

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Genentech

OpenAlex ID: W2097617059

FWCI: 6.327

Cites: 14

Cited by: 62

Related to: 10